NGMDF (NuGen Medical Devices) Change In Receivables: $0.05 Mil (TTM As of Mar. 2026)


What is NuGen Medical Devices Change In Receivables?

NuGen Medical Devices NGMDF Change In Receivables is $0.05 Mil as of Mar. 2026. The stock has 7 warning signs investors should review.

NuGen Medical Devices's change in receivables for the quarter that ended in Mar. 2026 was $0.04 Mil. It means NuGen Medical Devices's Accounts Receivable declined by $0.04 Mil from Dec. 2025 to Mar. 2026 .

NuGen Medical Devices's change in receivables for the fiscal year that ended in Dec. 2025 was $0.12 Mil. It means NuGen Medical Devices's Accounts Receivable declined by $0.12 Mil from Dec. 2024 to Dec. 2025 .

NuGen Medical Devices's Accounts Receivable for the quarter that ended in Mar. 2026 was $0.04 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. NuGen Medical Devices's Days Sales Outstanding for the three months ended in Mar. 2026 was 212.92.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NuGen Medical Devices's liquidation value for the three months ended in Mar. 2026 was $-11.98 Mil.

NuGen Medical Devices  (OTCPK:NGMDF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

NuGen Medical Devices's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.042/0.018*91
=212.92

2. In Ben Graham's calculation of liquidation value, NuGen Medical Devices's accounts receivable are only considered to be worth 75% of book value:

NuGen Medical Devices's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1.296-13.493+0.75 * 0.042+0.5 * 0.362
=-11.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices Change In Receivables Related Terms

NuGen Medical Devices Change In Receivables Historical Data

* Premium members only.

The historical data trend for NuGen Medical Devices's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices Change In Receivables Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial -0.12 0.05 -0.07 0.07 0.12

NuGen Medical Devices Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.02 0.05 -0.06 0.04

NuGen Medical Devices Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.05 Mil mean?
NuGen Medical Devices (NGMDF) has a Change In Receivables of $0.05 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NuGen Medical Devices and its competitors.
Is NuGen Medical Devices' Change In Receivables too high?
NuGen Medical Devices' current Change In Receivables is $0.05 Mil.
How does NuGen Medical Devices' Change In Receivables compare to ABT and SYK?
NuGen Medical Devices' Change In Receivables of $0.05 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NuGen Medical Devices and its competitors. NuGen Medical Devices's current Change In Receivables is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 21.8% below its estimated fair value. The current Change In Receivables is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current Change In Receivables is $0.05 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NuGen Medical Devices Business Description

Other Exchanges 79O:GermanyNGMD:Canada
Address 18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.